Projects

Here are some of our projects!

Testimonials

Latest News

If you are interested in the latest articles in the industry, take a sneak peek at our blog. You’ve got nothing to loose!

See blog
Anti-Aging Gene Therapy: Has The Time Arrived For True Anti-Aging Medicine?

Now in 2016 it is becoming increasingly clear that therapies are emerging which could seriously impact aspects of the human aging process. One of the most cutting-edge therapies that are now being tested is the use of viral vectors to lengthen telomeres, the DNA caps at the end of our chromosomes. Elizabeth Parrish, CEO of the […]

Read more
Human Gene Therapy Successfully Lengthens Telomeres

In a bold and courageous move Elizabeth Parrish, CEO of Bioviva USA inc. became the first human to be treated with two gene therapies that her company has developed, one to lengthen her telomeres and one to prevent aging-related loss in muscle mass. With this move, she follows the footsteps of other courageous scientists, such as […]

Read more
Promising Results From The First Human Gene Therapy Against Aging

The CEO of Bioviva USA Inc., Elizabeth Parrish, became the first person to undergo rejuvenative gene therapy in 2015, and results are now out – the procedure successfully lengthened her telomeres by the equivalent of 20 years View full post

Read more

Team

Meet the Bioviva Team

Elizabeth Parrish

Elizabeth Parrish

CEO

Elizabeth Parrish CEO is a humanitarian, entrepreneur and innovator, is a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of regenerative medicine modalities, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach and sits on the board of the International Longevity Alliance (ILA). She is an affiliated member of the Complex Biological Systems Alliance (CBSA), which is a unique platform for Mensa based, highly gifted persons who advance scientific discourse and discovery.

    Dr. Williams

    Dr. Williams

    CMO

    Dr. Williams is a radiologist with a passion for gene and cellular therapies that can be administered under image guidance. He also has an interest in image guided cancer therapies. He did research for several years with adenoviral vector technology for the treatment of cancer. He has spent the last five years involved in research using AAV technology. Dr. Williams obtained his medical degree from Louisiana State University and completed an internship in Internal Medicine followed by a residency in Radiology at The University Of South Alabama. In residency, he was selected for the RSNA Research Fellow award. He is board certified by The American Board of Radiology with additional training in image guided cancer and spine procedures. His research interest is in gene therapy and reprogramming of stem cells. He also has research interest in the use of CT and MRI guidance for minimally invasive procedures related to the spine and treatment of cancer.

      Avi Roy

      Avi Roy

      CSO

      Avi Roy is the President of the Biogerontology Research Foundation (BGRF), a UK-based charity founded to support ageing research and address the challenges of a rapidly ageing population. Avi is an Oxford based biomedical scientist, with degrees in biomedical science and computer science. His PhD research involved the rejuvenation of human skin using small molecules, and identifying accurate biomarkers of aging. Avi rejuvenated the skin cells taken from 80 year old patients by transplanting the mitochondria taken from 16 year old skin cells. Using transcriptomics, proteomics and computational biology Avi identified the pathways involved in the rejuvenation of skin, and ever since has been screening small molecules to replicate the regenerative process. His research has resulted in an advanced protocol for screening drugs that have geroprotective properties, which has identified twelve novel geroprotective drugs.

        David Kekich

        David Kekich

        David A. Kekich is a recognized authority on longevity science. In 1999, he founded "Maximum Life Foundation", a 501(c)(3) not-for-profit corporation dedicated to reversing human aging and aging related diseases. Since then, the Foundation, in concert with many of the world’s leading researchers, has developed a scientific road map to transform the elderly to biological youth. David first became intrigued with extreme life extension in 1977 after founding the country's largest life insurance master general agency, which raised $3.1 billion of premium income for First Executive Corp. This was where he was widely exposed to the realities and horrors of death from aging.

          Greta Blackburn

          Greta Blackburn

          Greta Blackburn after years of success in the entertainment industry appearing in films, on television, and in mini-series, Ms. Blackburn shifted her focus, began to build her health and fitness credentials by becoming the Founding Editor of Ms. Fitness Magazine in 1993, and the Founder of FITCAMPS (www.fitcamp.com), wellness retreats for adults, in 1994. From 2007 to December 2009, Ms. Blackburn as responsible for finding the money for the message of bringing Telomere Biology into the mainstream when she convinced the man who would later fund found TA Sciences to a conference in Palm Springs, CA. At that conference stem cell and telomere specialists Dr. Jerry Shea and Dr. Woody Wright discussed their work in the field. Subsequent to that meeting TA Sciences was born and TA-65 developed. Logically, Blackburn was brought on board as Marketing Director for TA Sciences, Inc. She successfully created and implemented the first TA Think Tank conference which took place in Palm Springs, California in 2007, and which welcomed leaders in the fields of stem cell technology, telomerase research, and related fields.

            Mark Rosenberg

            Mark Rosenberg

            Mark Rosenberg, MD, FACEP, is board certified from the American Academy of Anti-aging Medicine. He has worked in both oncology and with the internal mechanisms of cellular aging. He serves at both medical director and medical advisor to the top diagnostic and therapeutic companies.

              Alex Salinas

              Alex Salinas

              Alex Salinas is the Director of Marketing for Latin America. Alex has strong management skills and is fluently bilingual. She is an asset for the BioViva team. She holds a degree in marketing and is strong voice for medical cures.

                Please join us!

                We are gene therapy innovation leaders. We develop therapies to treat severe genetic disorders and cellular aging. We are working on several patents and are seeking strategic partnerships to help us make a positive step forward in our efforts to bring cures to aging populations and those who suffer monogenic disease.

                At the heart of Bioviva's product creation efforts is its broadly applicable gene therapy platform for the development of novel one time treatments for diseases with either ineffective or no clinical options.

                As well as investors we are seeking to engage the community to help us to make gene therapy the next revolution in medicine. If you are interested there is a lot you can do to help not just invest, we are seeking people to spread the word about our work, people to advocate for regenerative medicine, lobbying your government representatives and to push for gene therapy to be allowed. If you have a blog, write for a transhuman, longevity or regenerative medicine E-zine and would like to arrange an interview with us or join our circle of friends please get in touch, we would love to hear from you.

                Your Name (required)

                Your Email (required)

                Subject

                Your Message